Singletine

欣格列汀

Report date: 2024/01/02 11:51:44
NME

Base Information

Drug NameSingletine
Drug Alias NameDC-291407DC-407DC291407
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2Fatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCisen Pharmaceutical Co LtdShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of SciencesCisen Pharmaceutical Co Ltd
Inactive CompaniesGuangzhou Jiayue Pharmaceutical Technology Co Ltd
Active IndicationsDiabetes Mellitus, Type 2Fatty Liver
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A